CMV

Awarded Project: "CMV-vectored vaccine approaches to induce protective antibodies to HIV-1 Env"

May 14, 2018
CMV-vectored Vaccine Approaches to Induce Protective Antibodies to HIV-1 Env

Dr. Peter Barry recently received a two year grant from the National Institute of Allergy and Infectious Diseases (NIAID) to study “CMV-vectored vaccine approaches to induce protective antibodies to HIV-1 Env” (R21AI134618).  This proposal is an exploratory investigation into approaches that will (1) promote antibody responses to rhesus cytomegalovirus (RhCMV)-vectored SIV vaccines in the face of pre-existing RhCMV immunity, and (2) increase SIV antigen expression.